Daxor (DXR) Competitors

Daxor (NASDAQ:DXR) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, media sentiment, dividends, analyst recommendations, community ranking and risk.

Is DXR or PDEX more profitable?

Pro-Dex has a net margin of 9.17% compared to Daxor's net margin of 0.00%. Pro-Dex's return on equity of 16.74% beat Daxor's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Daxor	N/A	N/A	N/A
Pro-Dex	9.17%	16.74%	9.98%

Do institutionals & insiders hold more shares of DXR or PDEX?

1.3% of Daxor shares are held by institutional investors. Comparatively, 15.3% of Pro-Dex shares are held by institutional investors. 59.0% of Daxor shares are held by company insiders. Comparatively, 47.5% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the MarketBeat Community favor DXR or PDEX?

Pro-Dex received 153 more outperform votes than Daxor when rated by MarketBeat users. However, 100.00% of users gave Daxor an outperform vote while only 61.85% of users gave Pro-Dex an outperform vote.

Company	Underperform	Outperform
Daxor	Outperform Votes 1 100.00%	Underperform Votes No Votes
Pro-Dex	Outperform Votes 154 61.85%	Underperform Votes 95 38.15%

Do analysts rate DXR or PDEX?

Daxor presently has a consensus price target of $24.75, suggesting a potential upside of 201.83%. Pro-Dex has a consensus price target of $52.00, suggesting a potential upside of 13.71%. Given Daxor's higher possible upside, analysts plainly believe Daxor is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Daxor	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Pro-Dex	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has more volatility and risk, DXR or PDEX?

Daxor has a beta of -0.51, meaning that its stock price is 151% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.56, meaning that its stock price is 44% less volatile than the S&P 500.

Which has preferable earnings & valuation, DXR or PDEX?

Pro-Dex has higher revenue and earnings than Daxor.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Daxor	$2.61M	15.22	N/A	N/A	N/A
Pro-Dex	$56.80M	2.62	$2.13M	$1.54	29.69

Does the media prefer DXR or PDEX?

In the previous week, Daxor and Daxor both had 2 articles in the media. Pro-Dex's average media sentiment score of 0.53 beat Daxor's score of -0.33 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Daxor	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Pro-Dex	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pro-Dex beats Daxor on 8 of the 12 factors compared between the two stocks.